Rainmed Medical Limited (02297.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 0.16

From 52W high−55.41%

Volume327000.00

Market capHKD 213.17M

P/E (TTM)—

P/S (TTM)7.8x

Div yield—

Key dataSep 18, 2026

Open

HKD 0.16

From 52W high

−55.41%

Volume

327000.00

Market cap

HKD 213.17M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.7x

P/E (TTM)

—

RSI (14)

40.4

MomentumView details →

1D Return

+7.84%

YTD Return

−38.89%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−4.7x

EV/Sales

10.0x

P/S (TTM)

7.8x

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

30.34%

Net Margin

−285.29%

EBITDA Margin

−214.02%

ROE (TTM)

−20.26%

ROA (TTM)

−11.77%

Asset Turnover

0.04x

GrowthView details →

Revenue YoY

+0.42%

EPS YoY

+44.44%

FCF YoY

+73.73%

Revenue CAGR 3Y

−38.79%

EPS CAGR 3Y

+40.30%

EBITDA YoY

+19.47%

MomentumView details →

1D Return

+7.84%

YTD Return

−38.89%

1Y Return

−50.00%

RSI (14)

40.4

vs 50D SMA

−18.08%

vs 200D SMA

−33.27%

Capital & dividendView details →

Debt/Equity

0.55x

Current Ratio

2.43x

Quick Ratio

2.24x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

46.82M

Net Income (TTM)

−170.95M

Op. CF (TTM)

−125.05M

Latest newsMore news →

Runmed Medical-B (02297.HK) announced its interim results for the six months ended June 2026, with revenue of RMB 14.672 million, up 41% year-on-year, and a narrowed net loss of RMB 21.989 million from RMB 32.169 million in the same period last year.20d ago

Similar companies

Profound Medical Corp.PROF RxSight, Inc.RXST Edap Tms S.a.EDAP Solana CompanyHSDT Anika Therapeutics, Inc.ANIK Quipt Home Medical Corp.QIPT Find similar companies →

Latest newsMore news →

Runmed Medical-B (02297.HK) announced its interim results for the six months ended June 2026, with revenue of RMB 14.672 million, up 41% year-on-year, and a narrowed net loss of RMB 21.989 million from RMB 32.169 million in the same period last year.20d ago